{"organizations": [], "uuid": "e41974439a1c00eeb7d8936631b94b2582c1496c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180307.html", "section_title": "Archive News &amp; Video for Wednesday, 07 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-evoke-pharma-q4-loss-per-share-002/brief-evoke-pharma-q4-loss-per-share-0-02-idUSASB0C99Y", "country": "US", "domain_rank": 408, "title": "BRIEF-Evoke Pharma Q4 Loss Per Share $0.02", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.061, "site_type": "news", "published": "2018-03-08T05:42:00.000+02:00", "replies_count": 0, "uuid": "e41974439a1c00eeb7d8936631b94b2582c1496c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-evoke-pharma-q4-loss-per-share-002/brief-evoke-pharma-q4-loss-per-share-0-02-idUSASB0C99Y", "ord_in_thread": 0, "title": "BRIEF-Evoke Pharma Q4 Loss Per Share $0.02", "locations": [], "entities": {"persons": [], "locations": [{"name": "co", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-evoke pharma", "sentiment": "negative"}, {"name": "evoke pharma inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 7 (Reuters) - Evoke Pharma Inc:\n* EVOKE PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND RECENT HIGHLIGHTS\n* Q4 LOSS PER SHARE $0.02 * INCLUDED IN NET LOSS FOR Q4 OF 2017 WAS GAIN OF ABOUT $2.3 MILLION DUE TO CHANGE IN FAIR VALUE OF WARRANT LIABILITY\n* AS OF DECEMBER 31, 2017, COâ€™S CASH AND CASH EQUIVALENTS WERE APPROXIMATELY $7.7 MILLION Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-08T05:42:00.000+02:00", "crawled": "2018-03-08T17:11:57.009+02:00", "highlightTitle": ""}